Neal I. Goldman
Known title: DirectorCIK: 0001182567
Neal I. Goldman's purchase track record
How the stock did after each of Neal I. Goldman's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since May 25, 2022
Stock higher 6 months later
50%
3 months: 100%
Median 6-month return
+22.2%
3 months: +6.2%
Beat the S&P 500
50%
median +15.3% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/19/2022 | MLSS | $28K | +73.1% | +103.8% | +15.0% |
| 11/21/2022 | MLSS | $63K | +3.2% | +69.3% | +6.1% |
| 6/14/2022 | MLSS | $20K | +5.0% | -25.0% | +7.6% |
| 5/25/2022 | MLSS | $61K | +7.4% | -39.4% | +1.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| MLSS | ▲ Buy | Grant | 134,832 | $120K | 8/28/2024 | View on chart |
| MLSS | ▲ Buy | Grant | 22,127 | $12K | 4/23/2024 | View on chart |
| MLSS | ▲ Buy | Grant | 56,065 | $30K | 4/22/2024 | View on chart |
| MLSS | ▲ Buy | Grant | 125,000 | $79K | 12/11/2023 | View on chart |
| MLSS | ▲ Buy | Grant | 134,831 | $120K | 6/28/2023 | View on chart |
| MLSS | ▲ Buy | Open Market | 55,326 | $28K | 12/19/2022 | View on chart |
| MLSS | ▲ Buy | Open Market | 45,095 | $28K | 11/23/2022 | View on chart |
| MLSS | ▲ Buy | Open Market | 107 | $66 | 11/22/2022 | View on chart |
| MLSS | ▲ Buy | Open Market | 54,798 | $35K | 11/21/2022 | View on chart |
| MLSS | ▲ Buy | Open Market | 9,720 | $7K | 6/16/2022 | View on chart |
| MLSS | ▲ Buy | Open Market | 5,270 | $4K | 6/15/2022 | View on chart |
| MLSS | ▲ Buy | Open Market | 10,583 | $8K | 6/14/2022 | View on chart |
| MLSS | ▲ Buy | Grant | 30,488 | $25K | 6/13/2022 | View on chart |
| MLSS | ▲ Buy | Open Market | 54,851 | $49K | 6/1/2022 | View on chart |
| MLSS | ▲ Buy | Open Market | 13,208 | $12K | 5/25/2022 | View on chart |
| MLSS | ▲ Buy | Grant | 11,526 | $10K | 5/24/2022 | View on chart |
| MLSS | ▲ Buy | Grant | 11,186 | $10K | 5/23/2022 | View on chart |
| MLSS | ▲ Buy | Grant | 14,229 | $12K | 5/20/2022 | View on chart |
| MLSS | ▲ Buy | Grant | 10,000 | $9K | 5/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
MLSS Highlights Scalable Growth Platform for CompuFlo®
Milestone Scientific said it is building a scalable growth platform for its CompuFlo® medical business. The company aims to expand the product line and increase market reach. This announcement may support future revenue growth. The stock is trading near its 52‑week low but has support at $0.40.
MLSS Highlights Scalable Growth Platform for CompuFlo®. Milestone Scientific said it is building a scalable growth platform for its CompuFlo® medical business. The company aims to expand the product line and increase market reach. This announcement may support future revenue growth. The stock is trading near its 52‑week low but has support at $0.40.